Articles tagged with:

View all tags

Innovation

Australian innovation pilot aims to reduce cost of vaccination in developing world

GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.

Our Community

Polio Australia - support of polio retreat to help those affected

Polio is a disease that has virtually been forgotten by our community. Although vaccination implemented in Australia in the late 1950s has prevented new infections, polio survivors form the largest single physical disability group in the country.

Access to healthcare

The fight against malaria

For the past 30 years, GSK scientists have been working with other organisations across the globe with the aim to develop what could be the world’s first malaria vaccine.

Access to healthcare

Increasing medicine access across the world's poorest nations

GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.

How we do business

Harnessing the electrical language of the body to treat disease

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

How we do business

Open source: the future of medical discovery

There is growing recognition that no single research body or group has the know-how or resources to tackle the most widespread and persistent diseases. Fortunately, a growing number of scientists are engaged in open source innovation that removes barriers and creates a more transparent environment for medical discovery.

Access to healthcare

Giving babies a healthier start

Why are our scientists researching how to adapt an ingredient in mouthwash into a gel for newborn babies?

Back to top